Relatively High Company Efficiency Detected in Shares of Par Pharmaceutical in the Pharmaceuticals Industry (PRX, QCOR, MTXX, VPHM, EURX)
Below are the top five most-efficient companies in the Pharmaceuticals industry as ranked by Revenue Per Employee (RPE). Analysts use RPE as a measure to compare the productivity of companies in the same industry.
Par Pharmaceutical (NYSE:PRX) ranks first with an RPE of $2.08M; Questcor Pharmaceuticals (NASDAQ:QCOR) ranks second with an RPE of $1.98M; and Matrixx Initiatives (NASDAQ:MTXX) ranks third with an RPE of $1.98M.
Viropharma (NASDAQ:VPHM) follows with an RPE of $1.81M and Eurand NV (NASDAQ:EURX) rounds out the top five with an RPE of $1.59M.
SmarTrend is bearish on shares of VPHM and our subscribers were alerted to Sell on April 28, 2010 at $12.71. The stock has fallen 9.8% since the alert was issued.
Keywords: keywords: nyse:prx par pharmaceutical revenue per employee